ID   LNISi004-A
AC   CVCL_D6IY
DR   hPSCreg; LNISi004-A
DR   Wikidata; Q127382622
RX   PubMed=37875964;
CC   From: Laboratory of NeuroImmunology, Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IZ ! LNISi004-B
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=37875964; DOI=10.1186/s12987-023-00479-4; PMCID=PMC10598911;
RA   Studle C., Nishihara H., Wischnewski S., Kulsvehagen L., Perriot S.,
RA   Ishikawa H., Schroten H., Frank S., Deigendesch N., Du Pasquier R.,
RA   Schirmer L., Probstel A.-K., Engelhardt B.;
RT   "SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid
RT   barrier rather than endothelial cells or pericytes of the blood-brain
RT   barrier.";
RL   Fluids Barriers CNS 20:76.1-76.21(2023).
//